Papaverine Hydrochloride 30 mg per 1 mL injection, solution

Where it's made

This label doesn't name the factory that makes the drug. Companies don't have to print it on the label. The maker's name is often on the stock bottle your pharmacy used; you can ask the pharmacist. See the plants Oryza Pharmaceuticals Inc. names for other drugs.

Recalls

• Mar 14, 2022 · Class II · Vitae Enim Vitae Scientific, Inc.
  Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.
  Lots: Lot #: a) 20VPHI037, 20VPHI038, 20VPHI039, Exp 12/31/2022; 21VPHI021, 21VPHI022, 21VPHI023, Exp 6/30/2023; 21VPHI047, 21VPHI048, Exp 10/31/2023; b) 21VPHI023, Exp 6/30/2023

Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.

Product details

Generic drug

Papaverine: every company that makes it

Form

injection, solution, intravenous

Strength

30 mg per 1 mL

Approval

unapproved drug other

On the market since

Feb 1, 2021

Package NDCs

72516-024-10 72516-024-25

Official label

DailyMed (National Library of Medicine), updated Jan 9, 2025

Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?